Literature DB >> 35639196

Implication of N-glycolylneuraminic acid in regulation of cell adhesiveness of C2C12 myoblast cells during differentiation into myotube cells.

Shiori Go1,2, Chihiro Sato1,2, Masaya Hane1,2, Shinji Go2, Ken Kitajima3,4.   

Abstract

A transition of sialic acid (Sia) species on GM3 ganglioside from N-acetylneuraminic acid (Neu5Ac) to N-glycolylneuraminic acid (Neu5Gc) takes place in mouse C2C12 myoblast cells during their differentiation into myotube cells. However, the meaning of this Sia transition remains unclear. This study thus aims to gain a functional insight into this phenomenon. The following lines of evidence show that the increased de novo synthesis of Neu5Gc residues in differentiating myoblast cells promotes adhesiveness of the cells, which is beneficial for promotion of differentiation. First, the Sia transition occurred even in the C2C12 cells cultured in serum-free medium, indicating that it happens through de novo synthesis of Neu5Gc. Second, GM3(Neu5Gc) was localized in myoblast cells, but not in myotube cells, and related to expression of the CMP-Neu5Ac hydroxylase (CMAH) gene. Notably, expression of CMAH precedes myotube formation not only in differentiating C2C12 cells, but also in mouse developing embryos. Since the myoblast cells were attached on the dish surface more strongly than the myotube cells, expression of GM3(Neu5Gc) may be related to the surface attachment of the myoblast cells. Third, exogenous Neu5Gc, but not Neu5Ac, promoted differentiation of C2C12 cells, thus increasing the number of cells committed to fuse with each other. Fourth, the CMAH-transfected C2C12 cells were attached on the gelatin-coated surface much more rapidly than the mock-cells, suggesting that the expression of CMAH promotes cell adhesiveness through the expression of Neu5Gc.
© 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  CMP-Neu5Ac hydroxylase; GM3; Myoblast; Myotube; Neu5Gc; Sialic acid

Mesh:

Substances:

Year:  2022        PMID: 35639196     DOI: 10.1007/s10719-022-10049-9

Source DB:  PubMed          Journal:  Glycoconj J        ISSN: 0282-0080            Impact factor:   3.009


  30 in total

Review 1.  Dystroglycan: from biosynthesis to pathogenesis of human disease.

Authors:  Rita Barresi; Kevin P Campbell
Journal:  J Cell Sci       Date:  2006-01-15       Impact factor: 5.285

Review 2.  Making muscle: skeletal myogenesis in vivo and in vitro.

Authors:  Jérome Chal; Olivier Pourquié
Journal:  Development       Date:  2017-06-15       Impact factor: 6.868

Review 3.  Glycobiology of α-dystroglycan and muscular dystrophy.

Authors:  Tamao Endo
Journal:  J Biochem       Date:  2014-11-07       Impact factor: 3.387

4.  Dystroglycan function requires xylosyl- and glucuronyltransferase activities of LARGE.

Authors:  Kei-ichiro Inamori; Takako Yoshida-Moriguchi; Yuji Hara; Mary E Anderson; Liping Yu; Kevin P Campbell
Journal:  Science       Date:  2012-01-06       Impact factor: 47.728

5.  Control of muscle formation by the fusogenic micropeptide myomixer.

Authors:  Pengpeng Bi; Andres Ramirez-Martinez; Hui Li; Jessica Cannavino; John R McAnally; John M Shelton; Efrain Sánchez-Ortiz; Rhonda Bassel-Duby; Eric N Olson
Journal:  Science       Date:  2017-04-06       Impact factor: 47.728

6.  Hypoglycosylation of alpha-dystroglycan in patients with hereditary IBM due to GNE mutations.

Authors:  Marjan Huizing; Goran Rakocevic; Susan E Sparks; Ioanna Mamali; Alexey Shatunov; Lev Goldfarb; Donna Krasnewich; William A Gahl; Marinos C Dalakas
Journal:  Mol Genet Metab       Date:  2004-03       Impact factor: 4.797

7.  Muscle deficiency and neonatal death in mice with a targeted mutation in the myogenin gene.

Authors:  P Hasty; A Bradley; J H Morris; D G Edmondson; J M Venuti; E N Olson; W H Klein
Journal:  Nature       Date:  1993-08-05       Impact factor: 49.962

8.  MyoD or Myf-5 is required for the formation of skeletal muscle.

Authors:  M A Rudnicki; P N Schnegelsberg; R H Stead; T Braun; H H Arnold; R Jaenisch
Journal:  Cell       Date:  1993-12-31       Impact factor: 41.582

9.  Myomaker is a membrane activator of myoblast fusion and muscle formation.

Authors:  Douglas P Millay; Jason R O'Rourke; Lillian B Sutherland; Svetlana Bezprozvannaya; John M Shelton; Rhonda Bassel-Duby; Eric N Olson
Journal:  Nature       Date:  2013-07-18       Impact factor: 49.962

10.  ISPD produces CDP-ribitol used by FKTN and FKRP to transfer ribitol phosphate onto α-dystroglycan.

Authors:  Isabelle Gerin; Benoît Ury; Isabelle Breloy; Céline Bouchet-Seraphin; Jennifer Bolsée; Mathias Halbout; Julie Graff; Didier Vertommen; Giulio G Muccioli; Nathalie Seta; Jean-Marie Cuisset; Ivana Dabaj; Susana Quijano-Roy; Ammi Grahn; Emile Van Schaftingen; Guido T Bommer
Journal:  Nat Commun       Date:  2016-05-19       Impact factor: 14.919

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.